Close Cookie Popup
Cookie Preferences
By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts as outlined in our cookie policy.
Strictly Necessary (Always Active)
Cookies required to enable basic website functionality.
Cookies helping us understand how this website performs, how visitors interact with the site, and whether there may be technical issues.
Cookies used to deliver advertising that is more relevant to you and your interests.
Cookies allowing the website to remember choices you make (such as your user name, language, or the region you are in).

NICO.LAB closes $13M investment round

https://nlc-health.webflow.io/news/nico-lab
By
Anne Reijns
Apr 2021
5 min read
Click to copy this page's URL
By
Anne Reijns
Apr 2021
5 min read
Click to copy this page's URL

One of the first ventures NLC built (in 2015) has grown wings to fly. Recently NICO.LAB announced a major milestone: the closing of a whopping A$13M (€8.4M) pre-IPO round!After 5 years of tireless work, moving forward on that typical entrepreneurial journey with its ups and downs, massive efforts have resulted in this big success on the Australian continent. Great to see the appreciation by Australian investors who thoroughly believe in NICO.LAB'S potential and are willing and able to support the venture for years to come! NLC’s participation in NICO.LAB is estimated to be worth €12M.Big compliments to the NICO.LAB team!

About NICO.LAB

Computational support can almost instantly provide the required information to assist in treatment decisions. More advanced and faster decision making substantially improves the quality of life of stroke patients. Nico-lab has developed a portfolio of 6 algorithms that automatically analyse and quantify radiological images of acute stroke patients. By using Nico-lab’s tools physicians can interpret medical scans in a fast and objective way allowing them to assess stroke severity objectively and make quick, calculated decisions on treatments and monitoring. Learn more

Share this post
Click to copy this page's URL
News

Insights